JEREMIAH BRO: Open Payments
NPI 1104337781 · STILLWATER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 36 payments from 14 companies in 2025. Trend: 2023 $1,459 · 2024 $1,285 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $135 |
| ABIOMED | 2 | $104 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Abbott Laboratories | 1 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| United Therapeutics Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: VERQUVO, FARXIGA, LEQVIO, JARDIANCE, CAMZYOS, AMPLATZER AMULET, Kerendia, Tyvaso.
Industry payments across OK — which companies pay providers there.
